Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.

Clinical epigenetics - 7 Nov 2020

Zhang Ping, Zhang Mingzhi

Abstract excerpt

Peripheral T-cell lymphoma (PTCL) is a rare and heterogeneous group of clinically aggressive diseases associated with poor prognosis. Except for ALK + anaplastic large-cell lymphoma (ALCL), most peripheral T-cell lymphomas are highly malignant and have an aggressive disease course and poor clinical outcomes, with a poor remission rate and frequent relapse after first-line treatment. Aberrant epigenetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to CpG Islands
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenomics

Share to Histone Deacetylases

Share to Histones

Share to Lymphoma, T-Cell, Peripheral

Share to Repressor Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 33160401
DOI: 10.1186/s13148-020-00962-x
PMCID: PMC7648940

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.PMID 33160401Read ↗

Methylation alterations and advance of treatment in lymphomaSemantic proximity Read ↗

Histone Deacetylase Inhibitors for Peripheral T-cell Lymphomas: From Biology to Real-World TherapySemantic proximity Read ↗

Targeting epigenetic regulators in the treatment of T-cell lymphoma.Semantic proximity Read ↗

Histone Modifications and Their Targeting in Lymphoid MalignanciesSemantic proximity Read ↗

Peripheral T cell lymphomas: from the bench to the clinic.Semantic proximity Read ↗

Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomasSemantic proximity Read ↗

Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in ChinaSemantic proximity Read ↗

Management of T-cell malignancies: Bench-to-bedside targeting of epigenetic biology.Semantic proximity Read ↗

Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targetsSemantic proximity Read ↗

[Mutations in epigenetic and metabolic regulators in peripheral T-cell lymphoma].Semantic proximity Read ↗

TP53 and KMT2D mutations associated with worse prognosis in peripheral T-cell lymphomas.Semantic proximity Read ↗

Pathogenesis of Peripheral T Cell LymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.